Opin vísindi

Germline variants at SOHLH2 influence multiple myeloma risk

Skoða venjulega færslu

dc.contributor.author Duran-Lozano, Laura
dc.contributor.author Thorleifsson, Gudmar
dc.contributor.author Lopez de Lapuente Portilla, Aitzkoa
dc.contributor.author Niroula, Abhishek
dc.contributor.author Went, Molly
dc.contributor.author Thodberg, Malte
dc.contributor.author Pertesi, Maroulio
dc.contributor.author Ajore, Ram
dc.contributor.author Cafaro, Caterina
dc.contributor.author Olason, Pall I.
dc.contributor.author Stefansdottir, Lilja
dc.contributor.author Bragi Walters, G.
dc.contributor.author Halldorsson, Gisli H.
dc.contributor.author Turesson, Ingemar
dc.contributor.author Kaiser, Martin F.
dc.contributor.author Weinhold, Niels
dc.contributor.author Abildgaard, Niels
dc.contributor.author Andersen, Niels Frost
dc.contributor.author Mellqvist, Ulf Henrik
dc.contributor.author Waage, Anders
dc.contributor.author Juul-Vangsted, Annette
dc.contributor.author Thorsteinsdottir, Unnur
dc.contributor.author Hansson, Markus
dc.contributor.author Houlston, Richard
dc.contributor.author Rafnar, Thorunn
dc.contributor.author Stefansson, Kari
dc.contributor.author Nilsson, Björn
dc.date.accessioned 2023-02-18T01:04:01Z
dc.date.available 2023-02-18T01:04:01Z
dc.date.issued 2021-04
dc.identifier.citation Duran-Lozano , L , Thorleifsson , G , Lopez de Lapuente Portilla , A , Niroula , A , Went , M , Thodberg , M , Pertesi , M , Ajore , R , Cafaro , C , Olason , P I , Stefansdottir , L , Bragi Walters , G , Halldorsson , G H , Turesson , I , Kaiser , M F , Weinhold , N , Abildgaard , N , Andersen , N F , Mellqvist , U H , Waage , A , Juul-Vangsted , A , Thorsteinsdottir , U , Hansson , M , Houlston , R , Rafnar , T , Stefansson , K & Nilsson , B 2021 , ' Germline variants at SOHLH2 influence multiple myeloma risk ' , Blood Cancer Journal , vol. 11 , no. 4 , 76 . https://doi.org/10.1038/s41408-021-00468-6
dc.identifier.issn 2044-5385
dc.identifier.other 69289070
dc.identifier.other db520fad-60d7-4d97-b054-c069a23582fc
dc.identifier.other 85104540884
dc.identifier.other 33875642
dc.identifier.uri https://hdl.handle.net/20.500.11815/4003
dc.description Funding Information: This work was supported by grants from the Knut and Alice Wallenberg Foundation (2012.0193 and 2017.0436), the Swedish Research Council (2017-02023), the Swedish Cancer Society (2017/265), Stiftelsen Borås Forsknings-och Utvecklingsfond mot Cancer, the Nordic Cancer Union (R217-A13329-18-S65), EU-MSCA-COFUND 754299 CanFaster, the Myeloma UK and Cancer Research UK (C1298/A8362), a Jacquelin Forbes-Nixon Fellowship, and Mr. Ralph Stockwell. We thank Ellinor Johnsson and Anna Collin for their assistance. We are indebted to the clinicians and patients who contributed samples. Open access funding provided by Lund University. Publisher Copyright: © 2021, The Author(s).
dc.description.abstract Multiple myeloma (MM) is caused by the uncontrolled, clonal expansion of plasma cells. While there is epidemiological evidence for inherited susceptibility, the molecular basis remains incompletely understood. We report a genome-wide association study totalling 5,320 cases and 422,289 controls from four Nordic populations, and find a novel MM risk variant at SOHLH2 at 13q13.3 (risk allele frequency = 3.5%; odds ratio = 1.38; P = 2.2 × 10−14). This gene encodes a transcription factor involved in gametogenesis that is normally only weakly expressed in plasma cells. The association is represented by 14 variants in linkage disequilibrium. Among these, rs75712673 maps to a genomic region with open chromatin in plasma cells, and upregulates SOHLH2 in this cell type. Moreover, rs75712673 influences transcriptional activity in luciferase assays, and shows a chromatin looping interaction with the SOHLH2 promoter. Our work provides novel insight into MM susceptibility.
dc.format.extent 2061774
dc.format.extent
dc.language.iso en
dc.relation.ispartofseries Blood Cancer Journal; 11(4)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Hematology
dc.subject Oncology
dc.title Germline variants at SOHLH2 influence multiple myeloma risk
dc.type /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article
dc.description.version Peer reviewed
dc.identifier.doi 10.1038/s41408-021-00468-6
dc.relation.url http://www.scopus.com/inward/record.url?scp=85104540884&partnerID=8YFLogxK
dc.contributor.department Office of Division of Diagnostic and Support Services
dc.contributor.department Faculty of Industrial Engineering, Mechanical Engineering and Computer Science
dc.contributor.school Health Sciences


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu